Inflammation-induced hepatotoxicity in humans.

Area of Science:

• Biochemistry
• Clinical Medicine
• Toxicology

Background:

• Severe sepsis often leads to multiple organ failure, necessitating effective organ function monitoring.
• Conventional liver function tests lack specificity and have long half-lives, limiting their utility in detecting acute liver injury.
• Glutathione S-transferase A1-1 (GSTA1-1) is a specific biomarker with a short half-life, rapidly released into circulation post-liver damage.

Purpose of the Study:

• To evaluate plasma GSTA1-1 levels as a predictor of liver injury in severe sepsis.
• To assess GSTA1-1's ability to predict elevated transaminases in septic patients.
• To investigate the relationship between inflammation, hemodynamic instability, and liver damage in sepsis.

Main Methods:

• Plasma GSTA1-1 levels were measured using enzyme-linked immunosorbent assay (ELISA).
• The study involved healthy volunteers subjected to experimental endotoxemia and patients with severe sepsis/septic shock.
• Levels of Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-6 (IL-6) were also monitored.

Main Results:

• Experimental endotoxemia in healthy volunteers did not elevate GSTA1-1 levels, indicating no significant liver injury in this model.
• In septic patients, GSTA1-1 demonstrated 88% specificity and 86% positive predictive value for predicting increased transaminases on day 7.
• GSTA1-1 levels correlated with dobutamine infusion rate (r = 0.94, P = 0.02) but not IL-6 levels, suggesting hemodynamic instability is linked to liver damage.

Conclusions:

• GSTA1-1 is a valuable and specific biomarker for early detection of liver injury in severe sepsis.
• Hemodynamic instability, rather than the degree of inflammation, appears to be a key factor in sepsis-induced liver damage.
• GSTA1-1 offers a promising tool for monitoring liver function in critically ill septic patients.